Canadian medical technology manufacturer Thornhill Medical is planning to boost production of MADM, a mobile gas anaesthesia technology.
The portable inline direct injection gas vaporiser, which received approvals from both the US Food and Drug Administration and Health Canada, is designed to easily connect to any ventilator for easily delivering isoflurane and sevoflurane gas anaesthesia.
Go deeper with GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Said to be easy to use due to its small footprint, the lightweight technology features compact design making it ideal in more challenging environments such as forward-deployed surgical scenarios and field hospitals.
The vaporiser can easily be hand-carried or attached to Thornhill’s MOVES SLC integrated life-support system to stand up a forward surgical capability quickly.
Thornhill president and CEO Lesley Gouldie said: “We know that surgical care in the far-forward setting needs solutions that promote agility, mobility and are self-sufficient while overcoming contested logistics and supply chain interruptions.
“We are also experiencing an increased demand for our MOVES SLC integrated life-support system which is why it is imperative that we are ready to support our combat and humanitarian partners to help save more lives with our companion MADM technology.”
US Tariffs are shifting - will you react or anticipate?
Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.
By GlobalDataThe technology was initially developed with the US Marine Corps as its field anaesthesia system. It has been deployed in critical care scenarios, including in Ukraine.
Capable of automatically adapting its operation to any ventilator type it is connected, the technology has been assessed for field use by the US Army Aeromedical Research Laboratory and Air Force Medical Evaluation Support Activity.
